• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment

Kainos Laboratories Inc

+ Add to Watchlist

KA3:GR

3.805 EUR 0.010 0.26%

As of 02:09:59 ET on 04/17/2014.

Snapshot for Kainos Laboratories Inc (KA3)

Open: 3.805 Day's Range: 3.805 - 3.805 Volume: 0
Previous Close: 3.815 52wk Range: 3.464 - 9.241 1-Yr Rtn: -40.49%

Stock Chart for KA3

No chart data available.
  • KA3:GR 3.805
  • 1D
  • 1M
  • 1Y
3.815
Interactive KA3 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for KA3

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 17.35
Shares Outstanding (M) 4.56
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.40%
Cash Dividend (JPY) 7.5000
Dividend Ex-Date 03/27/2014
5 Year Dividend Growth 12.22%
Next Earnings Announcement 05/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for KA3

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for KA3

KAINOS Laboratories, Inc. manufactures and sells clinical reagents. The Company specializes in biochemical reagents as well as immune serum studies. Kainos Laboratories produces in-house products including measuring equipment and tools through focus on research and development. The Company also has a close relation with Hitachi Chemical Company for technological tie-up.

Toshimichi NakamuraChairmanShiro KamijiPresident
Hiroshi UeharaDirectorRi KurotaniDirector
More Company Profile & Key Executives for KA3

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil